During the last 15-20 years, researchers at the Department of Urology have systematically collected tissue samples and clinical data from patients with treated for bladder and prostate cancer. This has led to establishment of an important biobank in collaboration with the Department of Molecular Medicine (MOMA); the biobank and has for a decade been an important source of internationally recognized cancer research.
In prostate cancer the department is also involved in research in epidemiology, screening tools, lifestyle interventions as well as medical intervention studies. The molecular signatures of bladder and prostate cancers have also received special attention. Several important tissue micro arrays (TMA) have been developed in collaboration with the Department of Histopathology.
About the region
Hospitals located in central Jutland are part of Central Denmark Region.
The region is a public institution with three main tasks within welfare and regional development:
- Health and hospitals
- Specialised offers to socially marginalised groups and disabled
- Political driving force for growth through regional development
The Central Denmark Region has approximately 26,100 full-time employees and a budget of DKK 30 billions.
The largest part of the budget is spent on health.
The region is governed by 41 directly elected politicians.
The Central Denmark Region has 10 hospitals consolidated into five hospital units. Each unit has its own management and administration.